Inari Medical Corp (NARI) - מקדם חוב לטווח ארוך להון

Inari Medical, Inc. (NARI) develops tools for mechanical thrombectomy, as reflected in the price chart, where the debt-to-equity ratio stands at 0.07. The company generates revenue from the sale of catheters to clinics and surgeons. Simultaneously, the R&D division is implementing new solutions in interventional cardiology, expanding the application possibilities of its breakthrough systems.

To minimize risks during periods of volatility, it is essential for investors to monitor the issuer's financial stability. This ratio measures the proportion of long-term liabilities relative to equity, determining the company's degree of dependence on external debt financing. Analyzing the long-term debt-to-equity ratio allows for an assessment of the quality of the liability structure. For Inari Medical, Inc. (NARI), this balance is critical when scaling the production of mechanical thrombectomy systems. A low debt load confirms the company's ability to develop innovative medical devices without excessive credit pressure.